Affinity Asset Advisors

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.

ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.

Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

Tesseract Health provides devices for disease monitoring and prevention.

Hyperfine makes MRI accessible to every patient regardless of income or resources.